These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8502347)

  • 21. Principles of MHC class I-mediated antigen presentation and T cell selection.
    Ljunggren HG; Thorpe CJ
    Histol Histopathol; 1996 Jan; 11(1):267-74. PubMed ID: 8720469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct orientation of the alloreactive monoclonal CD8 T cell activation program by three different peptide/MHC complexes.
    Auphan-Anezin N; Mazza C; Guimezanes A; Barrett-Wilt GA; Montero-Julian F; Roussel A; Hunt DF; Malissen B; Schmitt-Verhulst AM
    Eur J Immunol; 2006 Jul; 36(7):1856-66. PubMed ID: 16761314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cytoplasmic and the transmembrane domains are not sufficient for class I MHC signal transduction.
    Gur H; Geppert TD; Wacholtz MC; Lipsky PE
    Cell Immunol; 1999 Feb; 191(2):105-16. PubMed ID: 9973532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The immunogenic potential of human fetal retinal pigment epithelium and its relation to transplantation.
    Rezai KA; Semnani RT; Patel SC; Ernest JT; van Seventer GA
    Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2662-71. PubMed ID: 9375586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How the T cell repertoire becomes peptide and MHC specific.
    Huseby ES; White J; Crawford F; Vass T; Becker D; Pinilla C; Marrack P; Kappler JW
    Cell; 2005 Jul; 122(2):247-60. PubMed ID: 16051149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MHC molecules and lymphocytes: evolutionary perspective.
    Płytycz B; Seljelid R
    Arch Immunol Ther Exp (Warsz); 1998; 46(3):137-42. PubMed ID: 9704145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of peptides in T cell alloreactivity is determined by self-major histocompatibility complex molecules.
    Obst R; Netuschil N; Klopfer K; Stevanović S; Rammensee HG
    J Exp Med; 2000 Mar; 191(5):805-12. PubMed ID: 10704462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positive and negative selection of T cell repertoires during differentiation in allogeneic bone marrow chimeras.
    Onoé K; Gotohda T; Nishihori H; Aranami T; Iwabuchi C; Iclozan C; Morohashi T; Ogasawara K; Good RA; Iwabuchi K
    Transpl Immunol; 2003; 12(1):79-88. PubMed ID: 14551035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunologic considerations for therapeutic strategies utilizing allogeneic hepatocytes: hepatocyte-expressed membrane-bound major histocompatibility complex class I antigen sensitizes while soluble antigen suppresses the immune response in rats.
    Scherer MN; Graeb C; Tange S; Dyson C; Jauch KW; Geissler EK
    Hepatology; 2000 Nov; 32(5):999-1007. PubMed ID: 11050050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversible MHC multimer staining for functional isolation of T-cell populations and effective adoptive transfer.
    Knabel M; Franz TJ; Schiemann M; Wulf A; Villmow B; Schmidt B; Bernhard H; Wagner H; Busch DH
    Nat Med; 2002 Jun; 8(6):631-7. PubMed ID: 12042816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Explaining high alloreactivity as a quantitative consequence of affinity-driven thymocyte selection.
    Detours V; Perelson AS
    Proc Natl Acad Sci U S A; 1999 Apr; 96(9):5153-8. PubMed ID: 10220434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alloreactivity is limited by the endogenous peptide repertoire.
    Morris GP; Ni PP; Allen PM
    Proc Natl Acad Sci U S A; 2011 Mar; 108(9):3695-700. PubMed ID: 21321209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incomplete tolerance to MHC antigens in irradiation chimeras: implications for MHC restriction and self tolerance.
    Blanden RV; Ashman RB; O'Neill HC; Woodhams CE; Kees UR; Andrew ME
    Immunol Rev; 1981; 58():25-36. PubMed ID: 7030923
    [No Abstract]   [Full Text] [Related]  

  • 34. The paradox of alloreactivity and self MHC restriction: quantitative analysis and statistics.
    Detours V; Perelson AS
    Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8479-83. PubMed ID: 10900009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alloreactivity.
    Eckle SB; Rossjohn J; McCluskey J
    Methods Mol Biol; 2013; 1034():3-39. PubMed ID: 23775729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular immune response to non-MHC plasma membrane antigens.
    Matsunaga T; Ohno S
    Transplant Proc; 1980 Sep; 12(3 Suppl 1):135-40. PubMed ID: 6159706
    [No Abstract]   [Full Text] [Related]  

  • 37. Role of MHC and antigens in T-cell development.
    Murphy KM
    Curr Opin Immunol; 1991 Feb; 3(1):26-31. PubMed ID: 2054111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physiology of alloreactivity: an interpretation.
    Klein J; Nagy Z
    Transplant Proc; 1981 Mar; 13(1 Pt 2):918-23. PubMed ID: 6973866
    [No Abstract]   [Full Text] [Related]  

  • 39. The molecular basis of alloreactivity.
    Lechler RI; Lombardi G; Batchelor JR; Reinsmoen N; Bach FH
    Immunol Today; 1990 Mar; 11(3):83-8. PubMed ID: 2186745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Why the MHC is important to the immune system.
    Langman RE; Cohn M
    Transplant Proc; 1981 Dec; 13(4):1797-9. PubMed ID: 6977216
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.